, , ,

<<


 >>  ()
Pages:     | 1 |   ...   | 5 | 6 ||

...

-- [ 7 ] --

424. Comhair S.A. Antioxidant responses to oxidant-mediated lung diseases / S.A. Comhair, S.C. Erzurum // Am. J. Physiol. Lung Cell. Mol. Physiol. 2002. 283. P. 246-255.

425. Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials / D. Genne [et al.] // Clin. Microbiol. Infect. 2003. 9.

. 949954.

426. Community-acquired pneumonia: influence of management practices on length of hospital stay / R. Laing [et al.] // Internal. Medicine J. 2004. Vol. 34, 3. P. 91-97.

427. Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome / F. Gutiyrrez [et al.] // Eur. J. Clin. Microbiol. Infect.

Dis. 2005. Vol. 24. P. 377-383.

428. Community-acquired pneumonia in a hospitalized community: etiologi cal study / M. Fernandez [et al.] // Rev. Med. Chil. 2003. Vol. 131, 5. P. 498 504.

429. Comparison of clarithromycin and amoxicillin / clavulanic acid for com munity-acquired pneumonia in a era of drug-resistent Strepoccus pneumonia / P.

Bonvehi [et al.] // Clin. Drug. Invest. 2003. 23. P. 491-501.

430. Crapo J.D. Oxidative stress as an initiator of cytokine release and cell dam age / J.D. Crapo // Eur. Respir. J. 2003. Vol. 22, 44. P. 4-6.

431. Cytoplasmatic glutathione peroxidase (Gpx-1) and resistence to oxida tive stress / W.S. Lim [et al.] // Selenium in Biology and Medicine.: 5th Int. Symp., July, 20-23, 1992. USA, 1992. P. 20.

432. Cui J.F. Gas chromatographic-mass spectrometric determination of 20(S)-protopanaxadiof and 20(S)-protopanaxatrioI for studyon human, urinary excre tion of ginsenosides after ingestion of ginsengpreparations / J.F. Cui, I. Bjorkhem, P.

Eneroth // J. of Chromatography Biomedical Sciences and Applications. 1992. Vol. 689. . 349-355.

433. Daignosis and manadgement of pneumonia and other respiratory infec tions / A. Fein [et al.]. Professinal Communications Inc., 1998. 288 p.

434. Davidson W.B. Change in the activity of glutathione peroxidase (GSH PI) in the tissues of sheep during Se depletion / W.B. Davidson, W.J. Blanchflower // Selenium in Biology and Medicine.: 5th Int. Symp., July, 20-23, 1992. USA, 1992.

P. 81.

435. De Castro F.R. Optimizing treatment outcomes in severe community acquired pneurhonia / F.R. De Castro, A. Torres // Am. J. Respir. Med. - 2003. Vol.

2. P. 39-54.

436. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study / W.S. Lim [et al.] // Thorax.

2003. Vol. 58. . 377382.

437. Deng J.C. The systemic Response to Lung infection / J.C. Deng // Clin.

Chest. Med. 2005. Vol. 26. P. 1-9.

438. Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment / J. Garnacho-Montero [et al.] // Scand. J. Infect. Dis. 2010. 42 (3). . 185-192.

439. Determination of the distribution of selenium between glutathione peroxi dase, selenoprotein P, and albumin in plasma / J.T. Deagan, J.A. Butler. B.A. Zachara [et. al.] // Anal. Biochem. 1993. Vol. 208. P. 176-181.

440. Dinitrosyl-dithiol-iron complezes, NO carries in vivo, as potent inhibit ers of human glutation reductase and glutation-S-transferase / M.A. Keese [et al.] // Biochem. Pharmacol. 1997. Vol. 54. P. 1307-1313.

441. Direct costs in aduite with community-acquired pneumonia in emer gency clinical hospital / S. Ratchina [et al.] // Proceedings of 19th European Congress of Clinical Microbiology and Infectious Diseases. Helsinki: Finland, 2009. - P. 28.

442. Distribution of selenium between selenoprotein P, glutathione peroxidase and aibumin in plasma / J. Butler [et al.] // Selenium in Biology and Medicine.: 5th Int. Symp., July, 20-23, 1992. USA, 1992. P. 61.

443. Duan P. Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor / P. Duan, Z.M.

Wang // Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002. Vol. 22, 7. . 515-517.

444. Dudas, V. Antimicrobial selection for hospitalized patients with pre sumed* community-acquired pneumonia: a survey of non-teaching US community hospitals / V. Dudas, A. Hopefl, R. Jacobs // Ann. Pharmacother. 2001 Vol. 34. P.

446-452.

445. Dworski R. Oxidant stress in asthma / R. Dworski // Thorax. 2000. Vol. 55, 2. . 51-53.

446. Edelstein P.M. Pneumococcal resistance to macrolides, lincosamides, ketolids, and streptogramin agents: molecular mechanisms and resistance pheno types / P.M. Edelstein // Clin. Infect. dis. 2004. 38, Suppl. 4. P. 322-327.

447. Effects of Astragalus membranaceus injection on nitric oxide and endo thelin concentration of intestinal mucosa after hemorrhage shock-reperfusion in rats / Z.Q. Hei [et al.] // Zhongguo Zhong Yao Za Zhi. 2004. Vol. 29(5). P. 444-447.

448. Effects of organic and inorganic selenium supplementation on selenoen zyme activity in blood lymphocytes, granulocytes, platelets and erytrocytes / K. M.

Brown [et. al.] // Clin Sci (Lond). 2000. Vol. 98. P. 593- 449. Effect of Panax ginseng extract on energy metabolism during in rats / E.V. Avakian [et al.] // Planta Med. 1984. Vol. 50, 2. . 151-154.

450. Etiology of community-acquired pneumonia treated in an ambulatory set ting / T.J. Marrie [et al.] // Respir. Med. 2005. Vol. 99. P. 60-65.

451. Etiology of sever pneumonia in the very elderly / A.A. El-Solh [et al.] // Am. J. Resp. Crit. Care Med. 2001. Vol. 163, 3. P. 645-654.

452. European Surveillance of Antimicrobial Consumption (ESAC): outpa tient antibiotic use in Europe / M. Ferech [et al.] // J. Antimicrob. Chemother. 2006. Vol. 58. . 401-407.

453. Expression of selenoproteins in monocytes and macrophages-implications for the immune system. / R. Ebert-Dumig [et. al.] // Med. Clin. 1999. Vol. 94, 3. P. 29-34.

454. Ewig S. Community acquired pneumonia. Epidemiologi, risk and prog nosis // Eur. Respir. Mon. 1997. Vol. 3. P. 13-35.

455. Ewig S. Severity assessment in community-acquired pneumonia / S.

Ewig, H.Schafer, A. Torres // Eur. Respir. J. 2000. Vol.16. P. 1193 - 1201.

456. Factors associated with unknown aetiology in patients with community acquired pneumonia / S. Ewig [et al.] // Eur. Respir. J. 2002. Vol. 20, 5. P.

1254-1262.

457. Factors impacting on length of stay and mortality of community acquired pneumonia / Garau J. [et al.] // Clin. Microbiol. Infect. 2008. Vol. 14. . 322-329.

458. File T.M. Antibiotic Selection, for Community-Acquired Pneumonia;

(from American Health Consultants) / T.M. File. Praha, 2004. 176 p.

459. Fausto D.S. Biological chemisty of elements / D.S. Fausto, P.J. Willams.

Cambrige, 2003. 678 .

460. Filaretov A.A. Effect of adaptogens on the activity of the pituitary adrenocortical system in rats / A.A. Filaretov // Bulletin of experimental biology and medicine. 1986. Vol. 101. P. 627-629.

461. Five year surveillance of Streptococcus pneumoniae resistance in Mos cow. Russia / S.V. Grudinina [et al.] // 15th ESCMID, Copenhagen, Denmark, April 2-5. 2005. P. 1776.

462. Flavonoids and tannins: Plant based antioxidant with vitamin character / A. Hassing [et al.] // Med. Hypothesis. 1999. Vol. 52. 5. . 479-481.

463. Folch S.A simple method for the isolation and purification of total lipids from animal tissues / S.. Folch, M. Less, A.G.H. Sloane-Stanley // J. Biol. Chem. 1957. Vol. 226. P. 497-509.

464. Folch J. A simple method for the isolation and purification of total lipids from animal tissues / J. Folch, M. Less, A.G.H. Sloane-Stanley // J. Biol. Chem. 1957. Vol. 226. P. 497-509.

465. Forman H.J. Reactive oxygen species and cell signaling. Respiratory burst in macrophage signaling / H.J. Forman, M. Torres // Am. J. Respir. Crit. Care Med. 2002. 166. P. 4-8.

466. Free radical oxidation and screening of antioxidants / S.M. Nikolayev [et al.] // Current situation and future trends of drug research and development from nat ural sources: International scientific conference. - Mongolia, 2010. P. 56-59.

467. Fulder S. The growth of cultured human fibroblasts treated with hydro cortisone and extracts of medicinal plant Panax ginseng // Experimental gerontology.

1977. Vol. 12. P. 125-131.

468. Govindarajan R. Studies on the antioxidant activities of Desmodium ga genticum / R. Govindarajan, S. Rastogi, M. Vijayakumar // Biol. Pharm. Bull. 2003.

Vol. 26, 10. P. 1424-1427.

469. Golubkina N.A. Selenium distribution in eggs of avian species / N.A. Go lubkina, T.T. Papazyan // Comparative biochemistry and Physiology, Part B: Bio chemistry and Molekular Biology. 2006. Vol. 145, 3-4. . 384-388.

470. Golubkina N.A. Selenium in food chain of Buriatia / N.A. Golubkina, G.

Alfthan, S.D. Munkueva // Twenty Years Of Selenium Fertilization: Proc. - Helsinki, Finland, 2005. P. 87.

471. Golubkina N.A. The human selenium status in 27 regions of Russia / N.A.

Golubkina, G.V. Alfthan // J. Trace Elem. Med. Biol. 1999. Vol. 13, 1-2. P.

15-20.

472. Grey G.C. Acute respiratory disease in the military / G.C. Grey // Fed.

Practioner. 1995. Vol. 12. P. 27-33.

473. Grimble R.F. Stress in disease: Metabolism on a knife edge // Clin. Nutr.

2001. Vol. 20, 6. . 469-476.

474. Guay D.R.P. Short-course antimicrobial therapy of respiratory tract infec tions // Drugs. 2003. 63. . 2169-2184.

475. Guidelines for the management of adult lower respiratory tract infections / M. Woodhead [et al.] // Eur. Respir. J. 2005. V.26. P. 1138-1180.

476. Gupta S. A new mitogen and interferon inducer // Clinical research. 1980. Vol. 28. P. 504.

477. Halliwell B. Free radicals as useful species / B. Halliwell, J.M.C. Gut teridge // Free radicals in biology and medicine Oxford: Oxford Univ. Press, 1999.

. 366-455.

478. Hallstrom T. Haemophilus influenzae and the complement system / T.

Hallstrom, K. Riesbeck // Trends Microbiol. 2010. 18(6). . 258-266.

479. Hao Y. Effect of Astragalus polysaccharides in promoting neutrophil vascular endothelial cell adhesion and expression of related adhesive molecules / Y.

Hao, Q.Y. Qiu, J. Wu // Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004. 24(5). . 427-430.

480. Huchon G. Guidelines for management of adult community-acquired lover respiratory tract infections / G. Huchon, M. Woodhead // Eur. Respir. J. 1998. 11. P. 986-991.

481. Hughes D.A. Effects of dietary antioxidants on the immune function of middle-aged adukts // Proc. Nutr. Soc. 1999. Vol. 58. P. 79-84.

482. Immunostimulating polysaccharides from Panax notoginseng / H. Gao [et al.] // Pharm. Res. 1996. Vol. 13. P. 1196-1200.

483. Immune modulation of human dendritic cells by complement / G. Castel lano, A.M. Woltman, N. Schlagwein // Eur. J. Immunol. 2007. Vol. 37, 10. P. 2803-2811.

484. Immunomodulatory effect of Panax ginseng C.A. Meyer in the Agents / Y.H. Cammisuli [et al.] // Actions. 1984. Vol. 15, 3-4. . 386-391.

485. Impact of initial antibiotic choice on clinical outcomes in community acquired pneumonia: analysis of a hospital claims-made database / R.B. Brown [et.

al.] // Chest. 2003. Vol. 123. P. 1503-1511.

486. Impact of statins and angiotensin-converting enzyme inhibitors on mortal ity of subjects hospitalised with pneumonia / E.M. Mortensen [et al.] // Eur. Respir. J.

2008. 31(3). . 611-617.

487. Impaired pulmonary inflammatory responses are a prominent feature of Streptococcal Pneumonia in mice with experimental emphysema / Sumito I. [et.al.] // Am. J. Respir. Crit. Care. Med. 2003. Vol. 167. P. 764-770.

488. Infectious Diseases Society of America/American Thoracic Society con sensus guidelines on the management of community-acquired pneumonia in adults / L.A. Mandell [et al.] // Clin. Infect. Dis. 2007. Vol. 44, Suppl. 2. . 27-72.

489. Influence of deviation from guidelines on the outcome of community acquired pneumonia / R. Menendez [et. al.] // Chest. 2002. Vol. 122. P. 612 617.

490. Jamyansan Ya. Flavanoids from rhodiola rosea in Mongjlian flora / Ya.

Jamyansan, J. Ganbaatar, S. Javzan // Current situation and future trends of drug re search and development from natural sources: International scientific conference. Mongolia, 2010. P. 54-56.

491. Kbiala J. Selenium and the organism / J. Kbiala // Cas. Lec. Cesk. 1999. Vol.138, 4. P. 99-106.

492. Kemmerich B. Efficacy and therapy of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bron chitis with pro ductive cough. A prospective, double-blind, placebo-controlled clini cal trial / B. Kemmerich, R. Eberhardt, H. Stammer // Arzneim. Forsch. J. Drug Res.

2006. Vol. 56(9). . 652-660.

493. Kemp A., A colorimetric micromethod for determination of glycogen in tissues / A. Kemp, A. Heijningen // Biochem. J. 1954. Vol.56. P. 646-648.

494. Kinnula V.L. Superoxide dismutases in the lung and human lung dis eases / V.L. Kinnula, J.D. Crapo // Am. J. Respir. Crit. Care Med. 2003. 167. P. 1600-1619.

495. Kiremidjian-Shumacher L. Selenium and immune function / L. Kiremid jian-Shumacher, M. Roy // Ernahrungswiss. 1998. Vol. 37, 1. P. 50-56.

496. Kollef M.H. Epidemiology, microbiology and outcomes of healthcare associated and community-acquired bacteremia: a multicenter cohort study / M.H.

Kollef, M.D. Zilberberg, .F. Shorr, L. Vo, J. Schein, S.T. Micek, M. Kim // J. In fect. 2011. Vol. 62, 2. P. 130-135.

497. Kothe H. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment / H. Kothe, T. Bauer, R. Marre //Eur.

Respir. J.-2008. Vol. 32. P. 139-146.

498. ozlov R.S. 7-years monitoring of resistance of clinical S. pneumoniae in Russia: results of prospective multicenter study (PEHASus) / R.S. Kozlov, O.V. Si vaja, L.S, Stratchounski // 45th Inlerscicnce Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Dec. 16-19. 2005. Washington DC, 2005. P.200-201.

499. Kraus J. Immunomodulating effect of polysaccharides from medicinal plants / J. Kraus, G. Frantz // Chem. Pharm. Bull. 1992. Vol. 40, 2. P. 314 317.

500. Kruse-Larres I.D. Free radicale // Arztl. Lab. 1990. Vol. 36, 11. P. 281-283.

501. Lakhanpaul M. Community acquired pneumonia in children: a clinical update / M. Lakhanpaul, M. Atkinson, T. Stephenson // Arch. Dis. Child. Pract. 2004. Vol. 89. P. 29-34.

502. Leitlinie der Deutschen Gesellschaft fur Pneumologie zur Diagnostik und Therapie von Patienten mit akutem und chronischem Husten / P. Kardos [et al.] // Pneumologie. 2004. Vol. 58. P. 570.

503. Levander O.A. Selenium / O.A. Levander, R.F. Burk // Present knowledge in nutrition. Washington: ILSI Press, 1996. P. 174-183.

504. Liam Ch.K. Community-acquired pneumonia in patients reguiring hospi talization / Ch.K. Liam, K.H. Lim, C.M.M. Wong // Respirology. 2001. Vol. 6, 3. . 259-264.

505. Lipid peroxidation, antioxidant enzymes activity, and trace element con centration in primary hypertension / B. Lacka, W. Grzeszak, K. Strojek // Trace Elem. Electrolytes. 1997. Vol. 14. P. 61-65.

506. Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone/ E.

Garcia Vazquez [et al.] // Eur. J. Clin. Microbiol. Infect. Dis. 2005. 24. P.

190-195.

507. Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes / X. Gao [et al.] // Pulm. Pharmacol. Ther. 2010. 23 (2). . 97-106.

508. Macnee W., Oxidants and antioxidants as therapeutic targets in chroni cobstructive pulmonary disease / W. Macnee, L. Rahman // Am. J. Respir. Grit. Care Med. 1999. Vol. 160, 5. P. 558-565.

509. Mahan D.C. Long-term effects of dietary organic and inorganic selenium sources and their progeny / D.C. Mahan, J.C. Peters // J. Anim. Sci. 2004. Vol.

82. P. 1343-1358.

510. Male fertility is linked to the selenoprotein phospholipid hydroperoxide glutathione peroxidase / C. Foresta [et al.] // Biol. Reprod. 2002. Vol.67. P.

967-971.

511. Mandell L.A. Epidemiology and etiology of community-acquired pneumonia // Infect. Dis. Clin. North. Am. 2004. Vol. 18. P. 761-776.

512. Mandell L.A. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults / L.A. Mandell, J.G.

Bartlett, S.F. Dowell // CID. - 2003. Vol. 37. P. 1405-1433.

513. Mandell L.A. Update on community-acquired pneumonia. New pathogens and new concepts in treatment / L.A. Mandell // Postgrad. Med. 2005. Vl. 18. P. 35-46.

514. Major metabolites of ginseng sapogenins formed by rat liver microsomes / R. Kasai [et al.] // Chem. and Farm. Bull. 2000. Vol. 48, 8. . 1226-1227.

515. Martinez B. The physiological effects of Aralia, Panax and Eleuthero coccus on exercised rats / B. Martinez, R.J. Staba // Jap. J. Pharmacol. 1984. Vol.

35, 2. P. 79-85.

516. McCartney E. Living longer, happier, Realthier? Selenium supplementa tion of human foods -the need to move forward / E. McCartney // Proc 21st Alltech Ann. Symp. Nutritional biotechnology in the feed and food industries. 2005. P.121-133.

517. Metabolism of selenite in men with widely varying selenium status / M.

Janchorbani [et. al.] // J. Amer. Coll. Nutr. 1999. Vol. 18, 5. P. 462-469.

518. etlay J.P. Testing strategies in the initial management of patients with community acquired pneumonia / J.P. etlay, M.J. Fine // Ann. Intern. Med. 2003. 138. . 109-118.

519. Merchant S. Factors association wiyh hospitalization costs for patients with community-acquired pneumonia / S. Merchant, C.D. Mulllins, Y.C. Shin // Clin.

Ther. 2003. 2. P. 593-610.

520. Microbial etiology of community-acquired pneumonia in the adult popu lation of 4 municipalities in Eastern Europe / C. Jokinen [et.al.] // Clin. Infect. Dis. 2001. Vol. 32. .1141-1154.

521. Microbiological profile of community-acquired pneumonia in adults over the last 20 years / L.S. Howard [et al.] // J. Infect. - 2005. Vol. 50. - P. 107 113.


522. Mills G.D. Effectiveness of beta lactam antibiotics compared with anti biotics active against atypical pathogents in non-severe community-acquired pneu monia: meta-analysis / G.D. Mills, M.R. Oehley, B. Arrol // B.M.J. 2005. Vol.

330. P. 456.

523. Mitchell I.B. The role of glutathione in radiation and drug induced cyto toxity / I.B. Mitchell, A. Russo // Brit. J. Cancer. 1987. Vol. 55, Suppl. 8. P.

96-100.

524. Mizgerd J.P. Acute lower respiratory tract infection / J.P. Mizgerd // N.

Engl. J. Med. 2008. 358. . 716-727.

525. Moore B.B. Role of T- and B- lymphocytes in pulmonary host defenses / B.B. Moore, T.A. Moore, G.B. Toews // Eur. Respir. J. 2001. 18 (5). . 846 856.

526. Moore T.A. Cytokine Immunotherapy during bacterial pneumonia: from benchtop to bedside / T.A. Moore, T.J. Standiford // Semin. Respir. Infect. 2001. Vol. 16, l. P. 27-37.

527. Morcillo E.J. Oxidative stress and pulmonary inflammation;

pharmacol ogical intervention with antioxidants / E.J. Morci1lo, L. Estrela, J. Cortijo // Parma col. Res. 1999. Vo1. 40, 5. P. 393-404.

528. Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection / N. Munoz [et al.] // Infect. Immun. 2010. 78(10).

. 4226-4233.

529. Mouthon L. Intravenous immunoglobulins in infectious diseases: where do we stand? / L. Mouthon, O. Lortholary // Clin. Microbiol. infect. 2003. 9(5). . 333-338.

530. Myiashita N. Etiology of community-acquired pneumonia requiring hos pitalization in Japan / N. Myiashita, H. Fukano, Y. Niki // Chest. 2001. Vol. 119.

p.1295-1296.

531. Nagaxawa H. Pathalogical aspects of active oxygen / free radicals / H.

Nagaxawa, C. Genka, M. Fujishima // Jap. J. Physiol. 1996. Vol. 46, 1. P.

15-32.

532. Niederman M.S. Guidelines for the management of adults with commu nity-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention / M.S. Niederman, L.A. Mandell, A. Anzueto // Am. J. Respir. Crit.

Care. Med. 2001. 163. . 54.

533. Niederman M.S. Cost-effective antibiotic management of community acquired pneumonia / M.S. Niederman // Europ. Respire. Mon. 2004. 28. .

198-210.

534. Oldfield J.E. Selenium / J.E. Oldfield. New York: World Atlas, 2001. 247 .

535. Opara E.C. Oxidative stress, micronutrients, diabetes mellitus and its complication / E.C. Opara // J. Roy. Soc. Promot. 2002. - Vol. 122, 1. . 28 34.

536. Ortqvist A. Treatment of community-acquired lower respiratory tract in fections in adults // Eur. Respir. J. 2002. Vol. 20 - P. 40-53.

537. Oxidative stress in lung epithelial cells from patients with idiopathic in terstitial pneumonias / K. Kuwano [et al.] // Eur. Respir. J. 2003. Vol. 21. P.

232-240.

538. Outpatient Care Compared with Hospitalization for Community-Acquired Pneumonia. A Randomized Trial in Low-Risk Patients / J. Carratala [et al.] // Eur.

Respir. J. 2005. Vol.142, 3. P. 165-172.

539. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia / R.T.

Sadikot [et al.] // Am J. Respir. Crit. Care Med. 2005. 171. . 1209-1223.

540. Pichter Ch. Oxidative stress / Ch. Pichter, B. Frei // Ed. Sies h. L.: Acad.

Press, 1985. P. 221.

541. Prognosis and outcome of patients with community-acquired pneumonia:

a meteanalysis / M.J. Fine [et al.] // JAMA. 1996. 275. . 134-141.

542. Prospective comparison of severity scores for predicting clinically rele vant outcomes for patients hospitalized with community-acquired pneumonia / P.


Yandiola [et al.] // Chest. 2009. Vol.135 (6). P. 1569-1572.

543. Rahman I. Oxidative Strees, Chromatin Remodeling and Gene Tran scription in Inflammation and Chronic Lung Diseases / I. Rahman // J. Biochem. and Mol. Biol. 2003. Vol. 36, 1. . 95-109.

544. Reduction of the door-to-needle time for administration of antibiotics in patients with a severe infection: a tailored intervention project / C.F. Van Tuijn [et al.] // Neth. J. Med. 2010. Vol. 68 (3). . 123-127.

545. Reese R. Handbook of Antibiotics / R. Reese, R. Betts, B. Gumustop // Lippincott Williams and Wilkins. 2000. 610 p.

546. Restrepo M.I. The role of gram-negative bacteria in healthcare associated pneumonia / M.I. Restrepo, A. Anzueto // Semin. Respir. Crit. Care. Med.

2009. 30. . 61-66.

547. Riesbeck K. Immunomodulating activity of quinolones: review / K. Ries beck // J. Chemother. 2002. 14(1). . 3-12.

548. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneu moniae: a case-control study / P.L. Ho [et al.] // Clin. Infect. Dis. 2001. 32. . 701-707.

549. Plohmann B. Immunomodulatory and antitumoral effects of triterpenoid saponins / B. Plohmann, G. Bader, K. Hiller, G. Franz // Pharmazie. 1997. - Vol. 52.

12. P. 953-957.

550. Ruhe J.J. Streptococcus pneumoniae bacteremia: duration of previous an tibiotic use and association with penicillin resistance / J.J. Ruhe, R. Hasbun // Clin.

Infect. Dis. 2003. Vol. 36. 1132-1138.

551. Sanchez F. Is azithromycin the first choice macrolide for treatment of community-acquired pneumonia? / F. Sanchez, J. Mensa, J. Martinez // Clin. Infect.

Dis. 2003. Vol. 36. P. 1239-1245.

552. Selenium and the immune system / R.C. McKenzie [et al.] // In Nutrition and immune function. UK.: CABI Publishing. Wallingford, 2002. P. 239-250.

553. Selenium deficiency increases the pathology of an Influenza virus infec tion / M.A. Beck [et al.] // FASEB L. 2001. Vol. 15. P. 1481-1483.

554. Selenium in Biology: facts and medical perspectives / J. Khrle [et al.] // Biol. Chem. 2000. Vol. 381. P. 849-864.

555. Selenium glutathione peroxidases, and some other antioxidar parameters in blood of patients with chronic renal failur / B.A. Zachara [et al.] // J. Trace Elem.

Med. Biol. 2001. Vol. 15. P. 161-166.

556. Selenium in blood and toenails in relation to human health in a selenifer ous area / M.P. Longnecker [et. al.] // Am. Clin. Nutr. 1991. 53. . 1288 1294.

557. Selenium in diet, blood and toenails in relation to human health selenifer ous area / M.P. Lohgnecker [et al.] // Amer. J. Clin. Nutr. 1991. Vol. 53. P.

1288-1294.

558. Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: effects of selenium yeast, selenite and selenate / G. Alfthan [et al.] // Am. J. Clin. Nutr. 1991. Vol. 53. P. 120-125.

559. Seyoum A. Structure radical scavenging relationships of flavonoids / A.

Seyoum, K. Asres, F.K. El-Fiky // Phytochemistry. 2006. Vol. 67. P.2058 2070.

560. Shantanova L.N. Plant adaptogenes in the traditional diet of nomads in Siberia and Mongolia / L.N. Shantanova, D.B. Dashiev // Current situation and fu ture trends of drag research and development from natural sources: In abstracts of International scientific conference. Ulaanbaatar, 2010. P. 80-82.

561. Shao B.M. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb / B.M. Shao [et al.] // Biochem Biophys Res Commun. 2004. 320(4). .1103-1111.

562. Shi F.S. Effect of Astragalus saponin on vascular endothelial cell and its function in burn patients / F.S. Shi, Z.G. Yang, G.P. Di // Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001. Vol. 21(10). P. 750-751.

563. Sies H.L. Oxidative stress / Ed. H.L. Sies. New York: Acad. Press, 1985. P. 73.

564. Statins and the risk of pneumonia: a population-based, nested case-control study / R.C. Schlienger [et al.] // Pharmacotherapy. 2007. 27(3). . 325-332.

565. Statins and outcomes in patients admitted to hospital with community ac quired pneumonia: population based prospective cohort study / S.R. Majumdar [et al.] // B.M.J. 2006. 333(7576). . 999.

566. Systemic cytokine levels in community-acquired pneumonia and their asso ciation with disease severity / G. Antuncs [et al.] // Eur. Respir. J. 2002. Vol.

20, 4. P. 990-995.

567. Stimulation of interieukin-8 production by acidic polysaccharides from the root of Panax ginseng / Y. Sonoda[et al.] // Immunopharmacology. 1998. Vol.

38(3). . 287-294.

568. Study of community aacquired (SCAPA) pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines / W.S. Lim [et al.] // Thorax. 2001. Vol. 56. . 296-301.

569. Study of serym level of selenium, IL-4, IL-10 and interferon gamma in with allergic asthma, allergic rhinitis and healthy controls / J. Ghaffari [et. al.] // Asthma. 2004. Vol. 5, 1. . 47.

570. Superoxide release and cellular glutathione peroxidase activity in leuko cytes from children with persistent asthma / L.E. Marzal [et. al.] // Braz. J. Med. Biol.

Res. 2004. 37 (11). P. 1607-1613.

571. Takahashi M. Pharmacological and physiological effects of ginseng on actions induced by opioids and psychostimulants / M.Takahashi, S. Tokuyama // Me thods and Findings in Experimental and Clinical Pharmacology. 1998. Vol. 20. . 77-84.

572. The Cytokine Handbook / Ed. by A.W. Thomson, M.T. Lotze. Lon don;

San Diego: Acad. Press, 2003. 156 p.

573. Yun X.Y. The influence of selenium of the protein associated ribosome of rat liver / X.Y. Yun, G.Y. Li // Selenium in Biology and Medicine.: 5th Int. Symp., July, 20-23, 1992. Vanderbilt univ. school of med., Nashville, Tennesse (USA), 1992. P. 55.

574. Yun X.Y. Phospholipid hydroperoxide glutathione peroxidase is a se lenoenzyme distant from the classical glutathione peroxidase. As avident from c DNA and amino acid sequencing // Free Radical Res. Comm. 1991. Vol. 14, 5 6. P. 343-362.

575. Validation of predictive rules and indices of severity for community ac quired pneumonia / S. Ewig [et al.] // Thorax. 2004. 59. . 421427.

576. Wang I.C. C60 and water-soluble derivatives as antioxidants against radical-initiated lipid peroxidation / I.C. Wang, L.A. Tai, D.D. Lee // J. ed. Chem. 1999. 42. . 4614-4620.

577. Waterer G.W. Wunderink Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia / G.W. Waterer, G.W. Somes // Arch. Intern.

Med. 2001. 161(15). . 1837-1842.

578. Whanger P.D. Selenocompounds in plants and animals and their biologi cal significance / P.D. Whanger // J. Amer. College Nutr. 2002. Vol. 21. P.

223-232.

579. Whanger P.D. Selenoprotein W: a review / P.D. Whanger // Cell. Mol.

Life Sci. 2000. Vol.57. P. 1846-1852.

580. Woodhead M. Community-acquired pneumonia: severity of fillness evaluation / M. Woodhead // Infect. Dis. Clin. North. Am. 2004. Vol. 18(4). P.

791-807.

581. Zabro M.T. Immunomodulation by macrolide antibiotics / M.T. Zabro, H. Abdelghaffar // J. of Chemotherapy. 2001. 13. . 3-8.



Pages:     | 1 |   ...   | 5 | 6 ||
 
 >>  ()





 
<<     |    
2013 www.libed.ru - -

, .
, , , , 1-2 .